GlassScriptPhysician profile
Esteban Escolar
NPI 1891965158
$1,057.90
in general payments reported to CMS, 2019-2025
16 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $38.64 · 2021: $77.80 · 2022: $385 · 2023: $57.31 · 2024: $124 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $368.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $390.17 | 2021-2022 | |
| Abbott Laboratories | $184.42 | 2019-2022 | |
| Boston Scientific Corporation | $175.89 | 2024-2025 | Watchman Flx, Ams 800 Artificial Urinary Sphincter |
| Janssen Pharmaceuticals, INC | $58.15 | 2022-2023 | Xarelto |
| Edwards Lifesciences Corporation | $38.64 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $33.72 | 2022-2025 | Eliquis |
| Myriad Genetic Laboratories, INC. | $25.64 | 2025 | Prolaris |
| Pfizer INC. | $22.52 | 2025 | |
| Medtronic Vascular, INC. | $20.69 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $18.35 | 2019 | |
| Inspire Medical Systems, INC. | $18.34 | 2025 | Inspire |
| Dexcom, INC. | $18.02 | 2024 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $18.00 | 2023 | |
| Irhythm Technologies, INC. | $17.69 | 2024 | Zio Xt Patch, Zio Monitor |
| Sumitomo Pharma America, INC. | $17.66 | 2025 | Gemtesa |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Esteban Escolar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.